This inventor holds 2 USPTO granted patents. Top assignees: Jiangsu Pacific Meinuoke Bio-Pharmaceutical Co., Ltd., Other. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 834,570 Years Active: 2021
Title: Qiang Feng: Innovator in Pharmaceutical Preparations
Introduction
Qiang Feng is a notable inventor based in Changzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable pharmaceutical preparations.
Latest Patents
Qiang Feng holds 2 patents. His latest patent involves a pharmaceutical preparation that stably comprises a CD147 monoclonal antibody. This preparation includes a buffer, a protein protectant, and a surfactant, which work together to maintain the stability of the CD147 monoclonal antibody over an extended period. The patent also outlines the use of this pharmaceutical preparation in creating a drug for treating CD147-related diseases, especially non-small cell lung cancer, along with a method for preparing the pharmaceutical preparation.
Career Highlights
Throughout his career, Qiang Feng has worked with Jiangsu Pacific Meinuoke Bio-Pharmaceutical Co., Ltd. This experience has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Hao Tang and Mingxi Chen. Their collaboration has likely fostered a productive environment for innovation and development in their projects.
Conclusion
Qiang Feng's work in pharmaceutical preparations showcases his dedication to improving treatments for serious diseases. His innovative patents and career achievements highlight his role as a significant contributor to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile